Induction of immune activation by a novel immunomodulatory oligonucleotide without thymocyte apoptosis

Biochemical and Biophysical Research Communications

Volumn 318, Issue 1, 2004, Pages 60-66

  Jiang, Weiwen ^a   Reich III, Charles F ^a   You, Dong ^b   Kandimalla, Ekamber ^b   Agrawal, Sudhir ^b   Pisetsky, David S ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HYBRIDON INC   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; CpG DNA; LPS; Oligonucleotide; Thymocyte

Indexed keywords

CORTICOSTERONE; DNA; HYB 2048; IMMUNOMODULATING AGENT; IMMUNOSTIMULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CPG ISLAND; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL SURVIVAL; CORTICOSTERONE; CPG ISLANDS; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; SPLEEN; THYMUS GLAND;

BACTERIA (MICROORGANISMS);

EID: 1942439788     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.001     Document Type: Article

References (49)

1. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., Furutani Y., Yano O., Kataoka T., Sudo T. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72:1984;955-962.
2. Pisetsky D.S., Reich C.F. Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Sci. 54:1994;101-107.
3. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
4. Stacey K.J., Sweet M.J., Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:1996;2116-2122.
5. Sparwasser T., Koch E.S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:1998;2045-2054.
6. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
7. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
8. Janssens S., Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 27:2002;474-482.
9. Martin M.U., Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta. 1592:2002;265-280.
10. Takeuchi O., Akira S. Toll-like receptors; their physiological role and signal transduction system. Int. Immunopharmacol. 1:2001;625-635.
11. Zimmermann S., Egeter O., Hausmann S., Lipford G.B., Rocken M., Wagner H., Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:1998;3627-3630.
12. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M., Weeranta R. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:1998;870-876.
13. Kawarada Y., Ganss R., Garbi N., Sacher T., Arnold B., Hammerling G.J. NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J. Immunol. 167:2001;5247-5253.
14. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1996;1840-1845.
15. Boggs R.T., McGraw K., Condon T., Flournoy S., Villiet P., Bennett C.F., Monia B.P. Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev. 7:1997;461-471.
16. Kandimalla E.R., Bhagat L., Wang D., Yu D., Zhu F.G., Tang J., Wang H., Huang P., Zhang R., Agrawal S. Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles. Nucleic Acids Res. 31:2003;2393-2400.
17. Kandimalla E.R., Yu D., Zhao Q., Agrawal S. Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships. Bioorg. Med. Chem. 9:2001;807-813.
18. Kandimalla E.R., Zhu F.G., Bhagat L., Yu D., Agrawal S. Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs. Biochem. Soc. Trans. 31:2003;654-658.
19. Kandimalla E.R., Yu D., Agrawal S. Towards optimal design of second-generation immunomodulatory oligonucleotides. Curr. Opin. Mol. Ther. 4:2002;122-129.
20. Agrawal S., Kandimalla E.R. Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med. 8:2002;114-121.
21. Agrawal S., Kandimalla E.R. Antisense and/or immunostimulatory oligonucleotide therapeutics. Curr. Cancer Drug Targets. 1:2001;197-209.
22. ′ -end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity Bioorg. Med. Chem. Lett. 10:2000;2585-2588.
23. ′ -end of CpG DNA affects immunostimulatory activity Bioconjugate Chem. 13:2002;966-974.
24. Bhagat L., Zhu L.F.G., Yu D., Tang J., Wang H., Kandimalla E.R., Zhang R., Agrawal S. CpG penta- and hexadeoxyribonucleotides as potent immunomodulatory agents. Biochem. Biophys. Res. Commun. 300:2003;853-861.
25. ′ -linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents Nucleic Acids Res. 30:2002;4460-4469.
26. Yu D., Zhu F.G., Bhagat L., Wang H., Kandimalla E.R., Zhang R., Agrawal S. Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties. Biochem. Biophys. Res. Commun. 297:2002;83-90.
27. Jiang N., Reich C.F., Monestier M., Pisetsky D.S. The expression of plasma nucleosomes in mice undergoing in vivo apoptosis. Clin. Immunol. 106:2003;139-147.
28. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:1999;2291-2298.
29. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA. 93:1996;2879-2883.
30. Harbour-McMenamin D., Smith E.M., Blalock J.E. Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect. Immun. 48:1985;813-817.
31. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:2002;1958-1968.
32. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301:2003;640-643.
33. Hanada T., Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13:2002;413-421.
34. Isogai E., Isogal H., Kimura K., Fujii N., Takagi S., Hirose K., Hayashi M. In vivo induction of apoptosis and immune responses in mice by administration of lipopolysaccharide from Porphyromonas gingivalis. Infect. Immun. 64:1996;1461-1466.
35. Zhang X.M., Morikawa A., Takahashi K., Jiang G.Z., Kato Y., Sugiyama T., Kawai M., Fukada M., Yokochi T. Localization of apoptosis (programmed cell death) in mice by administration of lipopolysaccharide. Microbiol. Immunol. 38:1994;669-671.
36. ′ -OH kinase pathway J. Immunol. 168:2002;5-8.
37. Yi A.K., Hornbeck P., Lafrenz D.E., Krieg A.M. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. J. Immunol. 157:1996;4918-4925.
38. Sparwasser T., Miethke T., Lipford G., Erdmann A., Hacker H., Heeg K., Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27:1997;1671-1679.
39. Besedovsky H.O., Del Rey A., Sorkin E., Lotz W., Schwulera U. Lymphoid cells produce an immunoregulatory glucocorticoid increasing factor (GIF) acting through the pituitary gland. Clin. Exp. Immunol. 59:1985;622-628.
40. Smith E.M., Blalock J.E. Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc. Natl. Acad. Sci. USA. 78:1981;7530-7534.
41. Tilders F.J., DeRijk R.H., Van Dam A.M., Vincent V.A., Schotanus K., Persoons J.H. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology. 19:1994;209-232.
42. -) subset. J. Immunol. 165:2000;5621-5630.
43. Kato Y., Morikawa A., Sugiyama T., Koide N., Jiang G., Lwin T., Yoshida T., Yokochi T. Augmentation of lipopolysaccharide-induced thymocyte apoptosis by interferon-γ Cell. Immunol. 177:1997;103-108.
44. van der Meer M.J., Sweep C.G., Rijnkels C.E., Pesman G.J., Tilders F.J., Kloppenborg P.W., Hermus A.R. Acute stimulation of the hypothalamic-pituitary- adrenal axis by IL-1 beta, TNF alpha and IL-6: a dose response study. J. Endocrinol. Invest. 19:1996;175-182.
45. Turnbull A.V., Rivier C. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 9:1995;253-275.
46. Spath-Schwalbe E., Born J., Schrezenmeier H., Bornstein S.R., Stromeyer P., Drechsler S., Fehm H.L., Porzsolt F. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J. Clin. Endocrinol. Metab. 79:1994;1212-1214.
47. Besedovsky H.O., Del Rey A., Klusman I., Furukawa H., Monge A.G., Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 40:1991;613-618.
48. Myers L.P., Krieg A.M., Pruett S.B. Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli. Int. Immunopharmacol. 1:2001;1605-1614.
49. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168:2002;4531-4537.